Welcome

United States HIV/AIDS Therapeutic Markets

 

  • Research Code : 5786-01-00-00-00
  • SKU : HC00261-NA-MR_03260
  • Share this :
  • Release Date : 05-Aug-1999
  • Region : North America
  • Request Study Sample

Availability: In stock

 
USD 3,950

* Required Fields

Pay By Invoice

Be the first to review this product



Table of Contents

United States HIV/AIDS Therapeutic Markets, Executive Summary

Introduction to the U.S. HIV/AIDS Therapeutics Market

Objectives and Purpose
Report Scope and Segmentation
Report Structure

Summary of Major Findings

Drivers Affecting the Total U.S. HIV/AIDS Therapeutics Market
Restraints Affecting the Total U.S. HIV/AIDS Therapeutics Market
Total Revenues and Revenue Growth Rates
Percent of Revenues by Product Type
Analysis by Major Segment
Competitive Analysis

United States HIV/AIDS Therapeutic Markets, Market Engineering Research Methodology

Frost & Sullivan's Market Engineering Forecasting Methodology for the Healthcare Industry

Frost & Sullivan's Market Engineering Forecasting Methodology for the Healthcare Industry

Research Sources

Secondary Sources
Primary Research

Pharmaceutical Forecast Model

Pharmaceutical Forecast Model
Population-Based Forecast
Market Model Assumptions
Research Limitations

Presentation of Market Engineering Measurements; Definition and their Strategic Significance

Presentation of Market Engineering Measurements; Definition and their Strategic Significance

Glossary of Terms

Glossary of Terms

United States HIV/AIDS Therapeutic Markets, Challenges in the U.S. HIV/AIDS Therapeutics Market

Identification of Challenges Facingthe U.S. HIV/AIDS Therapeutics Market

Identification of Challenges Facingthe U.S. HIV/AIDS Therapeutics Market
Need for Simple Potent Regimens
Penetrating Untapped Patient Population Boosts Market Share
Improving Minor Side-Effect Profiles of Drugs Greatly Boosts Compliance
Attracting Treatment-Naive Patients Ensures Positive Growth
Development of Resistance-Free Drugs Increase Uptake
Maximizing Patient Enrollment in Clinical Trials Attracts Potential End Users
Need for Clinical Trials Showing HIV Drugs Have No Interaction with Recreational Drugs
Offering Combination Products Expedites Market Growth
Limiting Use of Protease Inhibitors Provides Strong Growth for NNRTIs
Supporting Data Needed for New NNRTIs to Prevent Cannibalization

Market Engineering Research for the U.S. HIV/AIDS Protease Inhibitor (PI) Market

Market Overview and Definitions

Overview
Definition
Scope/Segmentation

Market Engineering Research Measurement System

Market Engineering Research Measurement System
Market Drivers
Market Restraints

Market Engineering Revenue Forecasts (1995-2005)

Patient Population (Demand Analysis)
Pricing Analysis
Revenues

Competitive Analysis

Competitive Structure
Market Share Analysis
Market Share Winners and Why
Market Share Losers and Why

Product Analysis

Products on the Market
Products in Clinical Trials

Market Engineering Research for the U.S. HIV/AIDS Nucleoside Reverse Transcriptase Inhibitor (NRTI) Market

Market Overview and Definitions

Overview
Definition
Scope/Segmentation
History

Market Engineering Research Measurement System

Market Engineering Research Measurement System
Market Drivers
Market Restraint

Market Engineering Revenue Forecasts (1995-2005)

Patient Population (Demand Analysis)
Pricing Analysis
Revenues

Competitive Analysis

Competitive Structure
Market Share Analysis
Market Share Winners and Why
Market Share Losers and Why

Product Analysis

Products on the Market
Products in Clinical Trials

Market Engineering Research for the U.S. HIV/AIDS Non-Nucleoside Inhibitor Market

Market Overview and Definitions

Overview
Definition
Scope/Segmentation
History

Market Engineering Research Measurement System

Market Engineering Research Measurement System
Market Drivers
Market Restraints

Market Engineering Revenue Forecasts (1995-2005)

Patient Population (Demand Analysis)
Pricing Analysis
Revenues

Competitive Analysis

Competitive Structure
Market Share Analysis
Market Share Winners and Why
Market Share Losers and Why

Product Analysis

Products on the Market
Products in Clinical Trials
Products in Development

United States HIV/AIDS Therapeutic Markets, Emerging HIV/AIDS Therapies

Market Overview and Definitions

Overview
Emerging Therapies by Product Class in Clinical Trials

United States HIV/AIDS Therapeutic Markets, Profiles of Strategically Targeted Companies

Profiles of Strategically Targeted Companies

Profiles of Strategically Targeted Companies


Sample Study






Related Research
WHY CHOOSE
FROST & SULLIVAN
RESEARCH ?

1. Primary Research

Our analysis is based on comprehensive primary research conducted with core market participants.

2. Global Coverage

Unparalleled coverage of geographies, our analyst & consultant teams are based in 42+ offices spanning the globe.

3. Breadth of Vertical Industries

We cover the broadest spectrum of markets to provide our clients with the most relevant analysis and transformational insights.

4. Visionary Innovation Research

With on-going transformational shifts, our visionary innovation research prepares you with information on key megatrends shaping the future of your industry.

5. Mega Trends

Mega Trends are global forces that transform business, societies and economies.

6. Convergence Research Coverage

Taking an approach of analysing a macro-to-micro impact, our convergence research helps you prepare against an impending 'Kodak moment'.